Similarly, Xu et al. examined the functional significance of S100A14 and HER2 by silencing S100A14, and found a subsequent reduction in HER2 phosphorylation and downstream signaling with concomitant reduction in the HER2-stimulated breast cancer cell proliferation [54]. The gene discussed is ERBB2; the disease is breast cancer.